RxNorm 2105649 NDC Crossover

larotrectinib 20 MG in 1 mL Oral Solution

Related NDC Codes to RxNorm Concept 2105649

The following NDC codes crossover to the RxNorm Concept 2105649. This list is useful when crossing over from a given RxNorm code and the user is trying to choose a drug or product included in the NDC directory.

NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Labeler Name	Status
50419-390	Vitrakvi	Larotrectinib	Capsule	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-391	Vitrakvi	Larotrectinib	Capsule	Oral	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-392	Vitrakvi	Larotrectinib	Solution, Concentrate	Oropharyngeal	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
50419-393	Vitrakvi	Larotrectinib	Solution, Concentrate	Oropharyngeal	Bayer Healthcare Pharmaceuticals Inc.	ACTIVE
71777-390	Vitrakvi	Larotrectinib	Capsule	Oral	Loxo Oncology, Inc.	ACTIVE
71777-391	Vitrakvi	Larotrectinib	Capsule	Oral	Loxo Oncology, Inc.	ACTIVE
71777-392	Vitrakvi	Larotrectinib	Solution	Oral	Loxo Oncology, Inc.	ACTIVE